The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...

Eli Lilly's donanemab gets CHMP backing for early Alzheimer's in select patients after trials show reduced disease ...

One of the few drug trials for a possible long Covid ended in disappointment. But lessons are leading to a second chance.

A man with one of the deadliest forms of brain cancer is now hopeful for the future after his tumor completely disappeared ...

Sarepta stock tanked Friday after a new patient death was uncovered, spurring an FDA request to halt shipments of an ...

For patients unable to withstand the increased toxicity of a four-drug regimen, the two most commonly used triplet regimens ...

The administration said it is fast-tracking clinical trials that would allow patients struggling with serious mental health ...

With few treatments available to treat Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of ...

Scientists at UCSF and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that occur in ...

Avalyn Pharma has drawn in another fundraising round, this time a $100 million oversubscribed series D to continue developing ...

One of the most common misconceptions I hear is that trials are only for people who are seriously ill. In reality, healthy ...